Dermatomyositis Clinical Trial
Have you or your loved ones been diagnosed with dermatomyositis?
You may be eligible to participate in a dermatomyositis clinical trial.
Have you or your loved ones been diagnosed with dermatomyositis? You may be eligible to participate in a dermatomyositis clinical trial.
Details for the study
Treatments and/or Procedures
Inclusion Criteria: - Male or female subjects ≥ 18 years of age - Diagnosis of at least probable idiopathic inflammatory myopathies (IIM) per European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) Classification Criteria which includes confirmation of dermatomyositis (DM) rash/manifestation, disease activity defined by presence of DM rash / manifestation or an objective disease activity measure - Disease severity defined by Physician global activity visual analog scale (VAS) with a minimum value of 2.0 cm on a 10 cm scale and MMT-8 ≤ 142 or CDASI total activity score ≥ 14. - Corticosteroid daily dose less than that or equal to 20 mg prednisolone equivalent Exclusion Criteria: - Cancer-associated myositis - Evidence of active malignant disease or malignancies diagnosed within the previous 5 years - Physician Global Damage score ≥ 3, or clinically relevant improvement between Screening Visit and Baseline